🧑🏼‍💻 Research - November 23, 2025

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

['Bousquet J', 'Sousa-Pinto B', 'Vieira RJ', 'Schünemann HJ', 'Zuberbier T', 'Bognanni A', 'Togias A', 'Samolinski B', 'Valiulis A', 'Williams S', 'Bedbrook A', 'Czarlewski W', 'Torres MJ', 'Shamji MH', 'Morais-Almeida M', 'Canonica GW', 'Vecillas LL', 'Dykewicz MS', 'Jacomelli C', 'Klimek L', 'Leemann L', 'Lourenço O', 'Palamarchuk Y', 'Papadopoulos NG', 'Pereira AM', 'Savouré M', 'Toppila-Salmi SK', 'Ventura MT', 'Yepes-Nuñez JJ', 'Cruz AA', 'Ciprandi G', 'Gemicioglu B', 'Giovannini M', 'Gradauskiene B', 'Jartti T', 'Jeseňák M', 'Kuna P', 'Kvedariene V', 'Larenas-Linnemann DE', 'Latiff AHA', 'Mohammad Y', 'Ohta K', 'Mahesh PA', 'Pali-Schöll I', 'Pfaar O', 'Regateiro FS', 'Roche N', 'Sofiev M', 'Taborda-Barata L', 'Ulrik CS', 'Rostan MV', 'Viegi G', 'Zhang L', 'Antó JM', 'Haahtela T', 'Cherrez-Ojeda I', 'Ivancevich JC', 'Khaltaev N', 'Yorgancioglu A', 'Abdullah B', 'Al-Ahmad M', 'Al-Nesf MA', 'Amaral R', 'Asllani J', 'Bergmann KC', 'Bernstein JA', 'Blaiss MS', 'Braido F', 'Camargos P', 'Carreiro-Martins P', 'Casale T', 'Cecchi L', 'Fiocchi AG', 'Giuliano AFM', 'Christoff G', 'Cirule I', 'Correia-de-Sousa J', 'Costa EM', 'Del Giacco S', 'Devillier P', 'Dokic D', 'Hossny E', 'Iinuma T', 'Irani C', 'Ispayeva Z', 'Julge K', 'Kaidashev I', 'Bennoor KS', 'Kraxner H', 'Kull I', 'Kulus M', 'Kupczyk M', 'Kurchenko A', 'La Grutta S', 'Miculinic N', 'Tuyet LLT', 'Makris M', 'Milenkovic B', 'Lee SM', 'Montefort S', 'Moreira A', 'Mullol J', 'Nadif R', 'Nakonechna A', 'Neffen HE', 'Niedoszytko M', 'Nyembue D', "O'Hehir R", 'Ogulur I', 'Okamoto Y', 'Olze H', 'Palomares O', 'Panzner P', 'Patella V', 'Pawankar R', 'Pitsios C', 'Popov TA', 'Puggioni F', 'Quirce S', 'Ramonaité A', 'Recto M', 'Repka-Ramirez MS', 'Roberts G', 'Robles-Velasco K', 'Rottem M', 'Salapatas M', 'Sastre J', 'Scichilone N', 'Sisul JC', 'Solé D', 'Soto-Martinez ME', 'Sova M', 'Tantilipikorn P', 'Todo-Bom A', 'Tsaryk V', 'Tsiligianni I', 'Urrutia-Pereira M', 'Valovirta E', 'Van Ganse E', 'Vasankari T', 'Wallace D', 'Wang Y', 'Worm M', 'Yusuf OM', 'Zidarn M', 'Gil-Mata S', 'Marques-Cruz M', 'Mahboub B', 'Ansotegui IJ', 'Romano A', 'Artesani MC', 'Barreto B', 'Becker S', 'Beghe B', 'Bouchard J', 'Bourgoin-Heck M', 'Brussino L', 'Buhl R', 'Calvo-Gil M', 'Dahl VC', 'Vizuete JAC', 'Charpin D', 'Chavannes NH', 'Chełmińska M', 'Cheng L', 'Chkhartishvili E', 'Chong-Neto HJ', 'Choudhury D', 'Chu D', 'Cingi C', 'Compalati E', 'Cvetkovski B', 'Da Silva J', "D'Amato G", 'Davies J', 'Di Bona D', 'Dimou MV', 'Teixeira MDC', 'Doulaptsi M', 'Pérez JMF', 'Gawlik R', 'Goksel O', 'Gómez MR', 'Gonzalez Diaz SN', 'Gotua M', 'Grigoreas C', 'Grisle I', 'Guzman MA', 'Tan RH', 'Hyland M', 'Ierodiakonou D', 'Karavelia A', 'Kisiel M', 'Kosnik M', 'Kritikos V', 'Lombardi C', 'Martini M', 'Meço C', 'Mesonjesi E', 'Mihaltan F', 'Moniuszko M', 'Naclerio R', 'Neisinger S', 'Ordak M', 'Paoletti G', 'Perdomo-Flores EA', 'Pham-Thi N', 'Prokopakis E', 'Yeverino DR', 'Rolla G', 'Romantowski J', 'Rouadi PW', 'Rukhadze M', 'Sakurai D', 'Salameh L', 'Sarquis FS', 'Kosak TS', 'Soyka M', 'Sozinova O', 'Specjalski K', 'Tomic-Spiric V', 'Vachova M', 'van Hage M', 'Koyuncu IV', 'Vichyanond P', 'Wagenmann M', 'Ko FWS', 'Werminghaus P', 'Xepapadaki VP', 'Xiang YK', 'Fonseca JA']

🌟 Stay Updated!
Join AI Health Hub to receive the latest insights in health and AI.

⚡ Quick Summary

The upcoming ARIA-EAACI 2024-2025 guidelines aim to enhance the management of allergic rhinitis through a comprehensive methodology that integrates evidence-to-decision frameworks and digitalised shared decision-making algorithms. This innovative approach emphasizes patient perspectives and incorporates planetary health considerations.

🔍 Key Details

  • 📅 Timeline: Development of guidelines for 2024-2025
  • 🤝 Collaboration: Developed in partnership with the European Academy of Allergy and Clinical Immunology (EAACI)
  • 🧠 Methodology: Utilizes the GRADE framework and AI-based tools for question generation
  • 📊 Evidence Sources: Includes randomized controlled trials and patient-generated data
  • 🌱 Focus: Incorporates evidence on planetary health

🔑 Key Takeaways

  • 📈 Evidence-to-Decision (EtD) frameworks guide the formulation of recommendations.
  • 🤖 AI tools are employed to analyze web searches and generate relevant guideline questions.
  • 🌍 Patient perspectives are prioritized through the inclusion of patient-generated data sources.
  • 💻 Digitalised decision algorithms will be developed to facilitate shared decision-making.
  • 🌿 Planetary health considerations are integrated into the guidelines.
  • 📚 Historical context: ARIA guidelines have evolved since their first edition in 1999.
  • 🔍 Systematic approach ensures transparency and rigor in guideline development.

📚 Background

The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been pivotal in shaping the management of allergic rhinitis since their inception in 1999. With each revision, the guidelines have adapted to incorporate new evidence and emerging technologies, reflecting the evolving landscape of allergy and asthma care. The upcoming ARIA-EAACI 2024-2025 guidelines represent a significant step forward, emphasizing a patient-centered approach and the integration of digital tools.

🗒️ Study

The methodology for developing the ARIA-EAACI 2024-2025 guidelines involves a systematic process that includes the identification and prioritization of guideline questions. This process is informed by input from key opinion leaders and the analysis of web search data using artificial intelligence. Each guideline question is evaluated through the EtD framework, ensuring that recommendations are based on the best available evidence.

📈 Results

The guidelines will feature recommendations that are not only evidence-based but also reflective of patient experiences and preferences. By incorporating diverse sources of evidence, including randomized controlled trials and patient-generated data, the ARIA-EAACI 2024-2025 guidelines aim to provide a comprehensive framework for managing allergic rhinitis effectively.

🌍 Impact and Implications

The ARIA-EAACI 2024-2025 guidelines are poised to significantly impact the management of allergic rhinitis and asthma. By leveraging digital technologies and focusing on patient-centered care, these guidelines will facilitate better decision-making processes for healthcare providers and patients alike. The integration of planetary health considerations also highlights the importance of sustainable practices in allergy management, paving the way for a more holistic approach to healthcare.

🔮 Conclusion

The development of the ARIA-EAACI 2024-2025 guidelines marks a crucial advancement in the field of allergy and asthma management. By embracing a methodology that prioritizes patient perspectives and utilizes innovative technologies, these guidelines are set to enhance the quality of care for individuals affected by allergic rhinitis. The future of allergy management looks promising, with a strong emphasis on evidence-based practices and shared decision-making.

💬 Your comments

What are your thoughts on the upcoming ARIA-EAACI guidelines? How do you think digital tools can enhance patient care in allergy management? 💬 Share your insights in the comments below or connect with us on social media:

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Abstract

The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA-ARIA 2024-2025-in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024-2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)-based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence-to-Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA-EAACI 2024-2025, such evidence is derived not only from randomised controlled trials but also-among others-from patient-generated data sources that better reflect the affected individuals’ perspectives. Moreover, ARIA-EAACI 2024-2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person-centred, digitally enabled and AI-assisted ARIA-EAACI 2024-2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.

Author: [‘Bousquet J’, ‘Sousa-Pinto B’, ‘Vieira RJ’, ‘Schünemann HJ’, ‘Zuberbier T’, ‘Bognanni A’, ‘Togias A’, ‘Samolinski B’, ‘Valiulis A’, ‘Williams S’, ‘Bedbrook A’, ‘Czarlewski W’, ‘Torres MJ’, ‘Shamji MH’, ‘Morais-Almeida M’, ‘Canonica GW’, ‘Vecillas LL’, ‘Dykewicz MS’, ‘Jacomelli C’, ‘Klimek L’, ‘Leemann L’, ‘Lourenço O’, ‘Palamarchuk Y’, ‘Papadopoulos NG’, ‘Pereira AM’, ‘Savouré M’, ‘Toppila-Salmi SK’, ‘Ventura MT’, ‘Yepes-Nuñez JJ’, ‘Cruz AA’, ‘Ciprandi G’, ‘Gemicioglu B’, ‘Giovannini M’, ‘Gradauskiene B’, ‘Jartti T’, ‘Jeseňák M’, ‘Kuna P’, ‘Kvedariene V’, ‘Larenas-Linnemann DE’, ‘Latiff AHA’, ‘Mohammad Y’, ‘Ohta K’, ‘Mahesh PA’, ‘Pali-Schöll I’, ‘Pfaar O’, ‘Regateiro FS’, ‘Roche N’, ‘Sofiev M’, ‘Taborda-Barata L’, ‘Ulrik CS’, ‘Rostan MV’, ‘Viegi G’, ‘Zhang L’, ‘Antó JM’, ‘Haahtela T’, ‘Cherrez-Ojeda I’, ‘Ivancevich JC’, ‘Khaltaev N’, ‘Yorgancioglu A’, ‘Abdullah B’, ‘Al-Ahmad M’, ‘Al-Nesf MA’, ‘Amaral R’, ‘Asllani J’, ‘Bergmann KC’, ‘Bernstein JA’, ‘Blaiss MS’, ‘Braido F’, ‘Camargos P’, ‘Carreiro-Martins P’, ‘Casale T’, ‘Cecchi L’, ‘Fiocchi AG’, ‘Giuliano AFM’, ‘Christoff G’, ‘Cirule I’, ‘Correia-de-Sousa J’, ‘Costa EM’, ‘Del Giacco S’, ‘Devillier P’, ‘Dokic D’, ‘Hossny E’, ‘Iinuma T’, ‘Irani C’, ‘Ispayeva Z’, ‘Julge K’, ‘Kaidashev I’, ‘Bennoor KS’, ‘Kraxner H’, ‘Kull I’, ‘Kulus M’, ‘Kupczyk M’, ‘Kurchenko A’, ‘La Grutta S’, ‘Miculinic N’, ‘Tuyet LLT’, ‘Makris M’, ‘Milenkovic B’, ‘Lee SM’, ‘Montefort S’, ‘Moreira A’, ‘Mullol J’, ‘Nadif R’, ‘Nakonechna A’, ‘Neffen HE’, ‘Niedoszytko M’, ‘Nyembue D’, “O’Hehir R”, ‘Ogulur I’, ‘Okamoto Y’, ‘Olze H’, ‘Palomares O’, ‘Panzner P’, ‘Patella V’, ‘Pawankar R’, ‘Pitsios C’, ‘Popov TA’, ‘Puggioni F’, ‘Quirce S’, ‘Ramonaité A’, ‘Recto M’, ‘Repka-Ramirez MS’, ‘Roberts G’, ‘Robles-Velasco K’, ‘Rottem M’, ‘Salapatas M’, ‘Sastre J’, ‘Scichilone N’, ‘Sisul JC’, ‘Solé D’, ‘Soto-Martinez ME’, ‘Sova M’, ‘Tantilipikorn P’, ‘Todo-Bom A’, ‘Tsaryk V’, ‘Tsiligianni I’, ‘Urrutia-Pereira M’, ‘Valovirta E’, ‘Van Ganse E’, ‘Vasankari T’, ‘Wallace D’, ‘Wang Y’, ‘Worm M’, ‘Yusuf OM’, ‘Zidarn M’, ‘Gil-Mata S’, ‘Marques-Cruz M’, ‘Mahboub B’, ‘Ansotegui IJ’, ‘Romano A’, ‘Artesani MC’, ‘Barreto B’, ‘Becker S’, ‘Beghe B’, ‘Bouchard J’, ‘Bourgoin-Heck M’, ‘Brussino L’, ‘Buhl R’, ‘Calvo-Gil M’, ‘Dahl VC’, ‘Vizuete JAC’, ‘Charpin D’, ‘Chavannes NH’, ‘Chełmińska M’, ‘Cheng L’, ‘Chkhartishvili E’, ‘Chong-Neto HJ’, ‘Choudhury D’, ‘Chu D’, ‘Cingi C’, ‘Compalati E’, ‘Cvetkovski B’, ‘Da Silva J’, “D’Amato G”, ‘Davies J’, ‘Di Bona D’, ‘Dimou MV’, ‘Teixeira MDC’, ‘Doulaptsi M’, ‘Pérez JMF’, ‘Gawlik R’, ‘Goksel O’, ‘Gómez MR’, ‘Gonzalez Diaz SN’, ‘Gotua M’, ‘Grigoreas C’, ‘Grisle I’, ‘Guzman MA’, ‘Tan RH’, ‘Hyland M’, ‘Ierodiakonou D’, ‘Karavelia A’, ‘Kisiel M’, ‘Kosnik M’, ‘Kritikos V’, ‘Lombardi C’, ‘Martini M’, ‘Meço C’, ‘Mesonjesi E’, ‘Mihaltan F’, ‘Moniuszko M’, ‘Naclerio R’, ‘Neisinger S’, ‘Ordak M’, ‘Paoletti G’, ‘Perdomo-Flores EA’, ‘Pham-Thi N’, ‘Prokopakis E’, ‘Yeverino DR’, ‘Rolla G’, ‘Romantowski J’, ‘Rouadi PW’, ‘Rukhadze M’, ‘Sakurai D’, ‘Salameh L’, ‘Sarquis FS’, ‘Kosak TS’, ‘Soyka M’, ‘Sozinova O’, ‘Specjalski K’, ‘Tomic-Spiric V’, ‘Vachova M’, ‘van Hage M’, ‘Koyuncu IV’, ‘Vichyanond P’, ‘Wagenmann M’, ‘Ko FWS’, ‘Werminghaus P’, ‘Xepapadaki VP’, ‘Xiang YK’, ‘Fonseca JA’]

Journal: Allergy

Citation: Bousquet J, et al. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms. 2025; (unknown volume):(unknown pages). doi: 10.1111/all.70100

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.